Your search returned 2 results.

Results
	1.	A phase 1, open-label, single-arm study evaluating the ocular safety of OTX-101 and systemic absorption of cyclosporine in healthy human volunteers. [electronic resource] by Karpecki, Paul M Weiss, Sidney L Kramer, William G O'Connor, Patrick Evans, David Johnston, Josh Jasper, April L Justice, Angela Ogundele, Abayomi B Devries, Doug Publication details: Clinical ophthalmology (Auckland, N.Z.) 2019 In: Clinical ophthalmology (Auckland, N.Z.) vol. 13 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Effect of OTX-101, a Novel Nanomicellar Formulation of Cyclosporine A, on Conjunctival Staining in Patients with Keratoconjunctivitis Sicca: A Pooled Analysis of Phase 2b/3 and 3 Clinical Trials. [electronic resource] by Smyth-Medina, Robert Johnston, Josh Devries, Douglas K Jasper, April Kannarr, Shane R Schechter, Barry A Shen Lee, Bridgitte Varghese, George Ogundele, Abayomi Darby, Charles H Karpecki, Paul Luchs, Jodi Producer: 20200617 In: Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics vol. 35 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

Refine your search